MRI of inhaled perfluoropropane can assess regional lung ventilation and monitor improvements in response to medication ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

“Emphysema is part of a group of lung conditions which comes under the umbrella term chronic obstructive pulmonary disease ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

As the doctors told Annette Stalley she might need to be put on a ventilator, she realised it was a situation of her own ...

UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...

The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.

Increasing Prevalence of Asthma and COPD: The rising incidence of asthma and chronic obstructive pulmonary disease (COPD) ...

The announcement that inhaled insulin will soon be available in India has understandably generated a lot of excitement and ...

HMPV is an old virus, cases of which have been increasing in the past few months. China saw a significant rise in cases of ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...